Cited by 1,021SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Open access

Ibarrondo, F. Javier, Fulcher, Jennifer A., Goodman-Meza, David, Elliott, Julie, Hofmann, Christian, Hausner, Mary A., Ferbas, Kathie G., Tobin, Nicole H., Aldrovandi, Grace M., Yang, Otto O.·2020·New England Journal of Medicine

DOI 10.1056/nejmc2025179PMC PMC7397184

Open this paper in CoChat — free account

Abstract

Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmc2025179

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Roubidoux, E. K., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 635
Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery
Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070348 · Cited by 367
Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus
Andraud, M., Lejeune, O., Musoro, J. Z., Ogunjimi, B., Beutels, P., & Hens, N. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002418 · Cited by 75
Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS Patients
Chang, S., Wang, J., Huang, L., Chen, Y., Fang, C., Sheng, W., Wang, J., Yu, C., & Yang, P. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.12.1455-1457.2005 · Cited by 32

Show all 5 references

Sorted by citations

Items 901–1,000 of 1,002

Quality-Quantity Trade-offs in Tests for Management of COVID-19-like EpidemicsPreprint
Sasikumar, H., & Varma, M. M. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2106.08591
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses
Gozlan, Y., Reingold, S. M., Koren, R., Halpern, O., Regev‐Yochay, G., Cohen, C., Biber, A., Picard, O., Mendelson, E., Lustig, Y., et al. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821001369
Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review
Moharir, K. S., Arora, S., Yende, S. R., Lohiya, G. K., & Shah, S. (2021) · The Open COVID Journal · doi:10.2174/2666958702101010065
Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff
Sim, M., Cockcroft, C., Darby, D., Ellis, C. R., Heaps, A. G., Scargill, J., & Garcez, T. P. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211030957
Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infectionPreprint
Fischer, J., Balz, V., Jazmati, D., Bölke, E., Freise, N. F., Keitel, V., Feldt, T., Jensen, B.-E. O., Bode, J. G., Lüdde, T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1858571/v1
Late reinfection with a different severe acute respiratory syndrome coronavirus-2 clade in a patient with refractory arterial hypertension: a case report
García‐Abellán, J., Galiana, A., Fernández‐González, M., Gonzalo-Jiménez, N., Ruiz‐García, M., Botella, Á., Sanchis-Sanchis, J., Mascarell, P., Vega, S. F., Masiá, M., et al. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03071-2
The Evidence for COVID-19 and The Restrictions on Medical Education and Research
Kudo, A., & Okada, E. (2021) · Journal of Japan Society of Computer Aided Surgery · doi:10.5759/jscas.23.124
Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
Delgado, R. B. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/s01.13.2021
Characterization of Specific Humoral Immunity in Asymptomatic SARS-CoV-2 Infection
Deng, Y., Zheng, J., Lin, Y., & Huang, A. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000024
Inmunidad humoral natural al año tras infección por SARS-CoV-2 en pacientes hospitalizados
Cabanes, L., Rubio, C., Martinez, O., & Naval, E. (2021) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2021.10.012
Effects of Aging and Associated Conditions on Humoral Responses to Respiratory Tract Infections
Frasca, D. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_5
Kinetics of the SARS-CoV-2 antibody response in immunocompetent convalescent patients: nationwide multicenter 15-month follow-up cohort studyPreprint
Movsisyan, M., Chopikyan, A. S., Kasparova, I., Hakobjanyan, G., Carrat, F., MEKINIAN, A., Sukiasyan, M., Rushanyan, M., Chalabyan, M., Sharif, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1023988/v1
Mathematics Achievement in Young Children Is Increased with a Cognitively Oriented Curriculum.
Rawl, R. K., & O'Tuel, F. S. (1983)
A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2
Kim, M., Poon, K. K.-Y., Miller, N., & Rubio-Gomez, H. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.935329
Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy
Homan, T., Fortunato, F., Corso, G., Lopalco, P. L., Prato, R., & Martinelli, D. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00582-9
Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection
Jiang, Y., Wei, X., Wang, H., & Li, G. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02860-4
Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19
Caselli, D., Cafagno, C., Loconsole, D., Giannini, A., Tansella, F., Saracino, A., Chironna, M., & Aricò, M. (2022) · Children · doi:10.3390/children9010041
COVID-19 seroprevalence in primary and secondary healthcare workers (HCWs)
Murphy, G. P., Garry, C., Baarsel, S. V., Coleman, T., Shovlin, B., Fogarty, C., Williams, C., Lang, P., Casey, C., Leonard, L., et al. (2021) · International journal of infection control · doi:10.3396/ijic.v17.21784
COVID-19 Reinfection and Its Diagnostic Approach
William, A., & Kaur, R. (2021) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/nvst/v2/4321f
Serological testing for COVID-19
Cheepsattayakorn, A., & Cheepsattayakorn, R. (2021) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2021.08.00248
Durable tracking anti-SARS-CoV-2 antibodies of cancer patients recovered from COVID-19Preprint
Huang, Y., Yu, J., Li, D., He, K., Liu, W., Wang, L., Chen, Y., Xie, C., & Wu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-428122/v1
SARS-CoV-2 Infection Generates Long-Lived Memory B Cells Against the Receptor Binding Domain of the Spike ProteinPreprint
Rouers, A., Tay, M. Z., Fong, S., Goh, Y. S., Chang, Z. W., Amrun, S. N., Yeo, N. K., Huang, Y., Hor, P. X., Loh, C. Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3985606
A Prospective Study of Clinical, Epidemiological and Serologic Status Features in a Paediatric Pcr Sars-Cov-2 Positive PopulationPreprint
Caballero, I. C., López, A. R., Sánchez, A. B., Ramos, M. I., Abancens, B. J., Pinedo, A. B., Martín, S. G., Sánchez, B. S., García-Bermejo, I., Arana, D. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1204817/v1
Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual
Ni, L., Ye, F., Qiao, Q., Yu, F., Yang, Y., Zhao, H. J., Zhang, L.-N., Cheng, M., Zhu, G., Li, X., et al. (2022) · National Science Open · doi:10.1051/nso/2021003 · Cited by 1
Pases sanitarios para COVID-19
Millán, G. M. O. (2021) · Cuadernos Filosóficos / Segunda Época · doi:10.35305/cf2.vi18.143
Determination of IgG and IgM against COVID- 19 for Recovered Patients at Different Intervals and by Different Techniques
Al-Hadidi, E. W., & Altobje, M. A. (2022) · Journal of Life and Bio Sciences Research · doi:10.38094/jlbsr30152
Severe acute respiratory syndrome coronavirus-2 IgG antibodies among health-care workers in a tertiary care hospital in Delhi India
Chhabra, M., Arora, S. K., Shulania, A., Panesar, S., Chauhan, A. K., Ganguly, K., Achra, A., Nirmal, K., & Duggal, N. (2021) · Journal of Patient Safety & Infection Control · doi:10.4103/jpsic.jpsic_15_21
PENGUKURAN ANTIBODI KUANTITATIF ANTIBODI ANTI-SARS-COV-2
Indonesia, U. M., & Tambunan, R. T. H. (2021) · Majalah Ilmiah METHODA · doi:10.46880/methoda.vol11no2.pp106-114
Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic
Lai, C., Potosky, A. L., McGuire, C., Lobo, T., Ahn, J., Haddad, B. R., Richards, E. W., Anand, P., Wright, K., Christenson, R. H., et al. (2022) · Journal of Oncology · doi:10.1155/2022/8798306
Dynamical Analysis of a COVID-19 Epidemic Model with Social Confinement and Acquired Immunity Loss
Ding, Y., & Kang, Y. (2021) · NODYCON conference proceedings series · doi:10.1007/978-3-030-81170-9_3
Recurrencia de la COVID-19: reporte de caso
Hidalgo-Carrera, J. A., Guerra, P. A., Serratos-Garduño, J. E., der Meden-Alarcón, J. W. V., Chaya-Hajj, M., & Ramírez-Valencia, M. F. (2022) · Revista del Hospital Juárez de México · doi:10.24875/rhjm.21000022
Self-administered, remote assessment of SARS-CoV-2 seroprevalence in health care workers
Card, L., Litwin, C. M., Curry, S. R., Mack, E. H., Nietert, P. J., & Meissner, E. G. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.01.025
Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients
Cabanes, L., Rubio, C., Martínez, O., & Naval, E. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.04.007
Antibody response after one and two doses of the BNT162b2 vaccine in nursing home residents: The CONsort-19 studyPreprint
Bousquet, J. J., Blain, H., Tuaillon, É., Gamon, L., Pisoni, A., Miot, S., Rolland, Y., & Picot, M. (2021) · doi:10.22541/au.162041939.97098496/v1
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2Preprint
Trombetta, B. A., Kandigian, S. E., Kitchen, R. R., Grauwet, K., Webb, P. K., Miller, G. A., Jennings, C. G. B., Jain, S. V., Miller, S. M., Kuo, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-224438/v1
Best-fit epidemiological models for COVID-19: New cases in KoreaPreprint
Shanafelt, D. W. (2020) · doi:10.31219/osf.io/74fmy
Volume 42 Number 1
(2021) · Microbiology Australia · doi:10.1071/mav42n1
Can cancer survivors donate convalescent plasma for the treatment of COVID-19?
Venniyoor, A. (2020) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_377_20
Antibody responses of COVID-19 patients according to symptoms and the presence of pneumonia
Korkusuz, R., & Karandere, F. (2022) · Family practice and palliative care · doi:10.22391/fppc.1049314
Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals
Takayama, Y., Komatsu, T., Wada, T., Nihonyanagi, S., Hoshiyama, T., Moriya, T., Shimamura, S., Kajigaya, N., Naito, M., Takeuchi, O., et al. (2022) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2022_89-511
Antibody Response to SARS-CoV-2 Infection in Non Vaccinated Health Care Personnel
Khanam, P. A., Hassan, M. S., Alam, M. S., Belal, M. H., Rahman, Z. F., Begum, T., & Khan, A. (2022) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v40i3.60303
Diverging Facts and Values
ten Have, H. (2022) · Advancing global bioethics · doi:10.1007/978-3-030-91491-2_5
Serological Investigation of COVID-19 Antibodies in Armenia
Nazaryan, I., Mnatsakanyan, S., & Pepanyan, N. (2022) · Advances in Infectious Diseases · doi:10.4236/aid.2022.122027
COVID-19: Clinical, Immunological, and Image Findings from Infection to Post-COVID Syndrome
de Sousa, G. F., Silva, G. A. D. S., Barros, B. R. D. S., de Aquino, R. C. A., de Lima, M. R. C. F., Cruz, L. C. D. O., de Oliveira, E. G., de Sá, I. W. A., Rodrigues, F. A. D. C., Oliveira, F. H., et al. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815050509122010007
Declining neutralizing antibody levels after SARS-CoV-2 mRNA vaccination: observational data from community point-of-care testing service in Brno, Czechia
Mravčík, V., Valachovičová, S. K., & Vobořil, J. (2022) · Central European Journal of Public Health · doi:10.21101/cejph.a7230
Implications of Delay in Compulsory Mask Wearing -- A What-if AnalysisPreprint
Kaiheng, B. T., Roby, C. A., Jw, W., & Tan, D. Y. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2011.11920
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
Whang, S. N., Shah, V. D., Pu, L., Sheth, P., Lucas, G. N., Lee, J., Lee, M. H.-Y., Lacy, C., Duerksen-Hughes, P. J., Filippov, V., et al. (2022) · Pathogens · doi:10.3390/pathogens11090958
Elevated Levels of Anti-SARS-Cov2 IgG Antibody in Health Care Workers in Hospitals From Hamadan Province, Iran: A Prospective Study
Jalili, E., Bashirian, S., Faryabi, M. R., Noroozbeygi, M., Daneshyar, E., Ghelichkhani, S., Khazaei, S., & Solgi, G. (2022) · Avicenna Journal of Clinical Microbiology and Infection · doi:10.34172/ajcmi.2022.13
SARS-CoV-2 IgG Antibody Seroprevalence in Children from the Amritsar District of Punjab
Kaur, A., Singh, N. P., Singh, K., Sidhu, S. K., Kaur, H., Jain, P., Kaur, M., & Jairath, M. (2022) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2022.54.3.173
Del covid-19 al poscovid-19: lecciones y desafíos
Ramı́rez-Santana, C., Acosta-Ampudia, Y., Monsalve, D. M., & Rojas, M. (2022) · Medicina · doi:10.56050/01205498.1665
Current Diagnostics of SARS-CoV-2
Chiu, C. Y., Xu, P., Servellita, V., & Abate, A. R. (2020) · Cell & Cellular Life Sciences Journal · doi:10.23880/cclsj-16000157
Demographic and clinical characteristics of COIVD-19 reinfection cases confirmed by genetic analysis: A Systematic review
Salarabedi, M.-M., Tabashiri, A., Arabpour, E., Sardaripour, A., Pouladi, A., Nariman, Z., Keramatinia, A., Bahadorimonfared, A., & Jarrahi, A. M. (2022) · Eastern Journal of Healthcare · doi:10.31557/ejhc.2022.2.1.50-55
Association of Time-Lines of COVID-19 Seropositivity with Antibody Ratio Levels
Mushtaq, S., Din, N. U., Shah, A. H., Riaz, O., Azam, K., & Khan, S. W. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72i3.7173 · Cited by 1
Assessment of the levels of antispike SARS-CoV-2 IgG antibodies and their association with clinical characteristics in cohort of patients in Saudi Arabia
AlGannas, N. S., Alghamdi, A., Hazazi, A., Alqahtani, N. S., Alshareef, M. N., Ahmed, M. H., Omer, A. A. M., & AlShehah, A. A. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1369_22
Comparison of SARS-CoV2 IgG Antibody Levels in Health Workers with and without a History of COVID-19 Infection after Heterologous Vaccination at Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
Puspalina, F., Kurniati, N., Salim, E. M., Yuniza, & Ahmad, Z. (2023) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v6i16.713
Kinetics of Covid-19 antibodies in terms of titre and duration among healthcare workers: A longitudinal study
Goenka, M. K., Goenka, U., Patil, V., Das, S. S., Afzalpurkar, S., Jajodia, S., MUKHERJEE, M., Shah, B. B., & Moitra, S. (2023) · The National Medical Journal of India · doi:10.25259/nmji_109_21 · Cited by 1
T Cell Immune Responses against SARS-CoV-2 in the With Corona Era
Oh, J.-E. (2022) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2022.28.4.211
Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection
Chowdhury, S. R., Chakrabarty, S., Chakraborti, M., & Das, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00009-6
Is There an End in Sight for the Global Coronavirus Disease 2019 Outbreak?
Kamalden, T. F. T., Gasibat, Q., & Samsudin, S. (2022) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_18_21
Dynamics of Antibody Responses after Asymptomatic and Mild to Moderate SARS-CoV-2 Infections: Real-World Data in a Resource-Limited Country
Sayabovorn, N., Phisalprapa, P., Srivanichakorn, W., Chaisathaphol, T., Washirasaksiri, C., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Nimitpunya, P., Mepramoon, E., et al. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8040185
Emerging Pandemic Infectious Disease Threats
Corry, D. B., Hotez, P. J., Bottazzi, M. E., Weatherhead, J. E., Maresso, A. W., Heckmann, E., & Bimler, L. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00031-9
Knowledge, Attitude, And Practice Among Healthcare Professionals Regarding the Myths On COVID-19 Vaccination: A cross-sectional questionnaire study and demystification
Lokesh Kumar, S., Naik, Z., Panwar, A., Sridhar, M. R., Keluskar, V. K., & Kumar, R. S. (2023) · Asia Pacific Journal of Health Management · doi:10.24083/apjhm.v18i1.1441
Determining clinical biomarkers to predict long-term SARS-CoV-2 antibody response among COVID-19 patients in Bangladesh
Ahmed, T., Hasan, S. M. T., Akter, A., Tauheed, I., Akhtar, M., Rahman, S. I. A., Bhuiyan, T. R., Ahmed, T., Qadri, F., & Chowdhury, F. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1111037
Investigation of the Change in Antibody Levels of COVID-19 RT-PCR Positive Patients Over Time
Çöplü, N., Kılınç, Ç., Özbek, R., Demir, C., Çalışır, B., & AHLATCIOGLU, Z. A. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20239915
Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with cancer and the impact of anti-tumor treatment on antibodies*
Wu, B., Liu, B., Jiang, X., Yuan, Y., Qin, W., Qin, K., Mei, Q., Zhang, L., Zhang, H., Hu, G., et al. (2021) · Oncology and Translational Medicine · doi:10.1007/s10330-021-0488-8
Design and Generation of MRNAS Encoding Conserved Regions of SARS-Cov-2 ORf1Ab for T Cell-Mediated Immune Activation
Nguyen, C. M., Luong, B. A., Tran, T. T., Nguyen, H., & Tran, L. S. (2023) · Future Virology · doi:10.2217/fvl-2023-0066
Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-Term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study
Shafiekhani, M., Mirjalili, M., Gholami, S., Vatankhah, P., Roozbeh, J., Mehrdad, G., Haem, E., Zare, Z., Jalali, S. S., Golshan, M., et al. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-28012-2_19
Inmunidad humoral para SARS-CoV-2 variante Alfa en poblacion salvadoreña donante de plasma convaleciente. Serie de casos
Rodriguez-Funes, M.-V., & Domínguez, R. (2023) · Revista de Educación en Cuidados Críticos (REduCrític) · doi:10.24875/recc.22000016
Adaptive Immunity In Type Two Diabetes Mellitus (T2dm) Patients With Sars-Cov-2 (Covid-19) Infection
ÖCAL, P. A. (2023) · doi:10.59287/pcshs.363
Coronavirus Vaccines
Perlman, S. M., & Denison, M. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00017-7 · Cited by 2
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020–April 2021
Bosserman, R. E., Farnsworth, C. W., O’Neil, C. A., Cass, C., Park, D., Ballman, C., Wallace, M. A., Struttmann, E. L., Stewart, H. B., Arter, O. G., et al. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.375
Immunological response in health care workers post COVID-19 vaccination
Sidhu, S. K., Singh, K., Kaur, S., Jairath, M., & Kaur, A. (2023) · Annals of Geriatric Education and Medical Sciences · doi:10.18231/j.agems.2023.006
Serology Screening for SARS-COV-2 Infection in Patients Undergoing Heart Transplantation and their Household Contacts
Schtruk, L. E., Miranda, J. S. D. S., Barbosa, G. I. F., Salles, A. L. F., Guimarães, T. C. F., Dantas, A. M. R., Salles, V. A., Cavalcante, V. N., Reis, E., Lobbe, L., et al. (2021) · Archives of Cardiology and Cardiovascular Diseases · doi:10.22259/2638-4744.0401005
Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses: A cross-sectional cohort study in the general population
Hanssen, D. A. T., Pagen, D. M. E., Penders, J., Brinkhues, S., Dukers–Muijrers, N. H. T. M., Hoebe, C. J. P. A., Savelkoul, P. H. M., & van Loo, I. H. M. (2023) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2023.100164
DIFFERENCES IN S-RBD ANTIBODY TITERS OF SARS-CoV-2 POST-VACCINATION AND POST-COVID-19 IN UMY EMPLOYEES THAT DO GENERAL MEDICAL CHECK UP AT AMC MUHAMMADIYAH HOSPITAL YOGYAKARTA
Suryanto, S., & Gugun, A. M. (2023) · Cerdika Jurnal Ilmiah Indonesia · doi:10.59141/cerdika.v3i7.637
Research progress on the neutralizing antibody response to SARS-CoV-2
Teng, S., & Qu, X. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0084
Characterization of B‐cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS‐CoV‐2 infection
Arons, E., Henry, K. N., Haas, C. J., Gould, M., Tsintolas, J., Mauter, J. T., Zhou, H., Burbelo, P. D., Cohen, J. I., & Kreitman, R. J. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29179
Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: Epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines
Mohapatra, R. K., Seidel, V., Kandi, V., & Rabaan, A. A. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-3603-2
COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2
Stratton, C. W., & Tang, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00053-8
T-cell responses in COVID-19 survivors six to eight months after infection: a longitudinal cohort study in PunePreprint
Suryawanshi, P. V., Patil‐Takbhate, B., Athavale, P. V., Kanitkar, S. A., Shivnitwar, S. K., Barthwal, M. S., Dole, S. S., Chavan, H., Jali, P., Pawale, S., et al. (2024) · doi:10.22541/au.170664359.92915235/v1
Identificação de preditores de gravidade e mortalidade em gestantes com COVID-19: análise de coorte retrospectiva
Aniceto, V. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-05012024-163508
Assessing Seroprevalence of SARS-CoV-2 Antibodies Among US College Students after School ReopeningPreprint
Feeder, S. E., Ratishvili, T., Carlson, B. L., Grill, D. E., Goergen, K. M., Kennedy, R. B., Ovsyannikova, I. G., & Poland, G. A. (2024) · medRxiv · doi:10.1101/2024.04.23.24305972
T Cell Responses to SARS-CoV-2 in Vaccinated Pregnant Women: A Comparative Study of Pre-Pregnancy and During-Pregnancy Infections
Shen, C., Hu, S.-Y., Hou, C.-P., Shen, C., & Cheng, C. (2024) · Vaccines · doi:10.3390/vaccines12111208
Coronaviruses
Mostafa, H. H., & Pinsky, B. A. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0093
Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points
Zhang, S., Kong, X., Zhen, Q., Wei, Y., Shi, C., Ding, S., Chen, L., Dong, C., Tian, H., Li, C., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70161
Coronaviruses
Mostafa, H. H., & Pinsky, B. A. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0093
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort
Mills, A. N., Dubois, B., Lesseur, C., Rommel, A., Tubassum, R., Kaplowitz, E., Boychuk, N., Stern, T. A., Chen, J., Lieb, W., et al. (2025) · Pregnancy Hypertension · doi:10.1016/j.preghy.2025.101205
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection
Odo, T., Haun, B. K., Williams, C. A., Ball, A. H., To, A., Wong, T. A. S., Ching, L. L., Nakano, E. T., Ry, A. V., Pessaint, L., et al. (2025) · COVID · doi:10.3390/covid5040044
Expression and Characterization of SARS-CoV-2 RBD Recovered from Inclusion Bodies in E. coli by Using Mild Solubilization Method and Immunogenicity Improvement Thereof
Srichandan, S., Meena, J., Ahuja, R., & Panda, A. K. (2025) · Indian Journal of Microbiology · doi:10.1007/s12088-025-01499-4
Changes in peripheral blood mononuclear cell electrical properties in response to viral exposure and vaccination
Clarke, K. S. P., Stewart, A. T., Sinclair, E. L., Lewis, R., Labeed, F. H., Dunn‐Walters, D. K., & Hughes, M. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-08724-6
The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients
Hara, A., Watanabe, S., Sawano, T., Sonoda, Y., Saito, H., Ozaki, A., Wakui, M., Zhao, T., Yamamoto, C., Kobashi, Y., et al. (2025) · Vaccines · doi:10.3390/vaccines13070750
Accelerated Biological Age as Predictor for Neutralizing Antibody Titers Against Sars-Cov-2 Virus Maintenance and Breakthrough InfectionPreprint
Yang, J., Lee, C.-L., Chiu, Y., Chiu, S. Y., Wang, L., Sheng, T. W., Wang, S.-C., Huang, S., Huang, S., Lin, C., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5356151
Impact of rotating night shift work on immune homeostasis among hospital employees during the COVID-19 pandemic
Lin, S.-C., Lin, C., Wu, S., Yang, C.-C., Chen, W., Tseng, P., Shih, F.-C., Nanda, J. D., & Chen, C. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157003
Persistence of SARS-CoV-2-IgG antibody durability in convalescent COVID-19 patients 6 months after the natural infection
Hua, Q., Zhang, P., Qin, S., Feng, B., Xiao, B., Zheng, G., Ye, T., Zheng, D., Mo, J., Liu, Y., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1623509
Durability of neutralizing antibody and T-cell responses in COVID-19 patients after infection and booster vaccination
Lin, Y., Jiang, X., Cao, J.-X., Guo, Q., Wu, M., Wu, S., Duan, L., Shen, Y. L., Zhan, B., Lin, J., et al. (2025) · Vaccine X · doi:10.1016/j.jvacx.2025.100718
PhenoAge acceleration predicts antibody persistence and breakthrough infection after SARS-CoV-2 vaccination and infection
Yang, J., Lee, C.-L., Chiu, Y., Chiu, S. Y., Wang, L.-J., Sheng, T.-W., Wang, S.-C., Huang, S.-C., Huang, S.-H., Lin, C.-M., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102989
Molecular and Serological Tests for SARS-CoV-2 Detection in Indeterminate Serology: Can We Skip the Second Sample?
Sirakov, I. N., Shishkova, K., Shishkov, S., & Alexiev, I. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47110919 · Cited by 2
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial
Horton, D. B., Ukey, R., Madhvi, A., Andrews, T., Parmar, V., Reilly, N., Mäkelä, S. M., Peterson, J., Hustad, L., Wong, G., et al. (2025) · Infection · doi:10.1007/s15010-025-02697-4
Additional file 1 of Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
van Dam, K. P. J., Volkers, A., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Kempen, Z. L. E., Killestein, J., Tas, S. W., Boekel, L., Wolbink, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22914635
Additional file 1 of A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
Lee, C. C., Segaloff, H. E., Cole, D., Rosenblum, H. G., Morgan, C. N., Somers, T. S., Desamu-Thorpe, R., Foster, M. A., Currie, D. W., Ruff, J. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19498051

Authors: Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O.
Affiliations: University of California, Los Angeles (US)
David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
Corresponding author: Yang, Otto O.
ORCID: Ibarrondo, F. Javier
Fulcher, Jennifer A.
Hofmann, Christian
Ferbas, Kathie G.
Tobin, Nicole H.
Aldrovandi, Grace M.
Yang, Otto O.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-09-10
Volume: 383
Issue: 11
Pages: 1085-1087
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmc2025179
PMC: PMC7397184
OpenAlex: W3044311014
Cited by: 1,021
References: 5
Citations by year: 2026: 12 · 2025: 28 · 2024: 36 · 2023: 92 · 2022: 198 · 2021: 476 · 2020: 177
FWCI: 30.93
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: McCarthy Family Foundation
AIDS Healthcare Foundation (Grant to OOY)
National Institutes of National Institute of Allergy and Infectious Diseases (AI124979, AI131879, AI140775, UM1AI068616, UM1AI068632, UM1AI106716)
Doris Duke Charitable Foundation (2019086)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
James B. Pendleton Charitable Trust
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords: SARS-CoV-2, COVID-19 pandemic, antibody persistence, anti-spike antibodies, receptor binding domain, mild COVID-19, antibody waning
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, Antibodies, Viral, Female, Humans, Immunoglobulin G, Male, Middle Aged, Pneumonia, Viral, Coronavirus Infections, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks